Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference59 articles.
1. Ramírez-Moya, J., Wert-Lamas, .L, Acuña-Ruíz, A., Fletcher, A., Wert-Carvajal, C., McCabe, C. J., Santisteban, P. & Riesco-Eizaguirre, G. (2022). Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor. Scientific Reports 12(1), 7706.
2. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33.
3. Tian, J., & Luo, B. (2022). Identification of three prognosis-related differentially expressed lncRNAs driven by copy number variation in thyroid cancer. Journal of Immunology Research, 2022, 9203796.
4. Zeng, Z., Teng, Q., & Xiao, J. (2021). Long noncoding RNA ILF3-AS1 aggravates papillary thyroid carcinoma progression via regulating the miR-4306/PLAGL2 axis. Cancer Cell International, 21(1), 322.
5. Davies, L., & Welch, H. G. (2014). Current thyroid cancer trends in the United States. JAMA Otolaryngology. Head & Neck Surgery, 140(4), 317–322.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献